Charles Schwab Investment Management Inc Candel Therapeutics, Inc. Put Options Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CADL
# of Institutions
64Shares Held
8.14MCall Options Held
112KPut Options Held
130K-
Northpond Ventures, LLC1.94MShares$16.5 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.34MShares$11.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY823KShares$7.01 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA754KShares$6.42 Million0.5% of portfolio
-
Halter Ferguson Financial Inc. Carmel, IN681KShares$5.8 Million2.42% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $246M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...